Curriculum

CURRENT POSITION

-Head of the Anatomic Pathology Division, Integrated Activity Department of Onco-Hematology, University Hospital of Ferrara.

-Full Professor, academic discipline MED/08, Anatomic Pathology. Department of Translational Medicine, Ferrara University.

QUALIFICATIONS

-Master in Management for Medical Director, University of Ferrara. 17/07/2025

-National Scientific Qualification as Full Professor, academic discipline MED/08 – Anatomic Pathology. 29/03/2021.

-National Scientific Qualification as Associate Professor, academic discipline MED/08 Anatomic Pathology. 7/01/2014.

-PhD in "Biotechnology applied to Pathology". University of Modena and Reggio Emilia. 25/02/2000.

-Specialization in Anatomic Pathology. University of Messina. 29/10/1994, mark 50/50 and honors.

-Master’s Degree in Medicine and Surgery. University of Catania. 06/07/1990, mark 110/110 and honors.

PROFESSIONAL POSITIONS

-Deputy Head of the Anatomic Pathology Division, Integrated Activity Department of Onco-Hematology, University Hospital of Ferrara. 2018 - 31/10/2025

-Head of Molecular and Therapeutic Pathology and Hematopathology Unit, University Hospital of Ferrara. 25/10/2022 - 31/10/2025

-Associate Professor, academic discipline MED/08, Anatomic Pathology. Department of Translational Medicine, Ferrara University. 01/05/2015 - 30/12/2025

-Highly Specialized Professional Position in "IT Management". Pathology U.O.C., University Hospital of Ferrara. 01/11/ 2013 - 24/10/2022.

-Attending Pathologist. Pathology U.O.C., University Hospital of Ferrara. 4/03/2002 – 30/04/2015.

-Attending Pathologist. Cytodiagnostics Unit, Azienda USL Ferrara. 31/12/2001 – 3/03/2002.

ABROAD EXPERIENCE

-Visiting Clinician pathologist: Division of Hematopathology - Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, (USA) (Prof. Glauco Frizzera, M.D.). January-July 2004.

-Visiting Clinician Program: Neuropathology - Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, (USA) (Prof.ssa Caterina Giannini M.D., Ph.D.) May 2015.

MANAGEMENT ACTIVITY

-Member of the Department of Translational Medicine Board, University of Ferrara.

-Member of the Educational Planning Technical Commission (CTP), Medicine and Surgery Master’s Degree, University of Ferrara.

SCIENTIFIC ACTIVITY

Research activities are carried out mainly in the field of neoplastic pathology of the large intestine with studies about pathological, immunohistochemical and molecular characterization of colon cancer for purposes of prognostic stratification and for detection of hereditary syndrome. Research activities are also carried out in collaboration with national and international research groups with studies not only on colorectal cancer, but also on other solid tumors.

Scientific studies were carried out within research projects funded by MIUR, AIRC, CNR, Lega Italiana per la lotta contro I tumori, University of Ferrara and Emilia Romagna Region.

Author of 104 publications in international peer-reviewed journals and over 120 presentations at national and international meetings.

h-index: 36 (Source: Scopus); total number of citations 5628 (source SCOPUS)

MEMBERSHIP IN SCIENTIFIC SOCIETIES

-United States and Canadian Academy of Pathology (USCAP)

-American Society of Clinical Pathology (ASCP)

-European Society of Pathology (ESP)

-Society for Hematopathology (SH)

-Società Italiana di Anatomia Patologica e Citologia (SIAPEC)

Member of the following study groups:

Gruppo Italiano di Ematopatologia (GIE), GIPAD (Gruppo Italiano Patologi dell’Apparato Digerente (GIPAD), Gruppo Italiano di Neuropatologia (GINP), Gruppo Italiano di Patologia Molecolare e Medicina Predittiva (PMMP)

TEACHING ACTIVITY

-Professor of Anatomic Pathology in the following Degree Courses of the University of Ferrara:

Medicine and Surgery Master’s Degree

Dentistry Master’s Degree

Biomedical Laboratory Techniques Degree

-Professor of Anatomic Pathology in the following Medical Specialization Schools of the University of Ferrara: Haematology, Medical Oncology, Clinical Pathology and Clinical Biochemistry, Emergency Medicine, Medicine and Palliative Care, Orthopedics and Traumatology, Anesthesia, Intensive Resuscitation and Pain Therapy, Radiodiagnostics. Microbiology and Virology, Neurosurgery, Digestive Tract Diseases.

-Member of the Academic Board of the PhD Program in Medical, Omics and Oncology Sciences, University of Ferrara.

CLINICAL CARE ACTIVITY

-High experience and skill as a general pathologist with special focus in hematopathology, gastrointestinal pathology and molecular diagnostics, since 2002 to 2025 signed out over 70,000 histopathological cases, over 7,500 biotechnological and biomolecular diagnoses, over 19,000 cytopathological cases and performed 280 autopsies.

Deals with IT management of the Anatomic Pathology Division, University Hospital of Ferrara, covering all related aspects (laboratory management, reporting, and monitoring of diagnostic activities).

-Deputy Head of the Anatomic Pathology Division, University Hospital of Ferrara. 2018 - 31/10/2025.

-Head of Molecular and Therapeutic Pathology and Hematopathology Unit, University Hospital of Ferrara. 25/10/2022 - 31/10/2025

-Highly Specialized Professional Position in "IT Management". Pathology U.O.C., University Hospital of Ferrara. 01/11/ 2013 - 24/10/2022.

RESEARCH PROJECTS

-2024: Fondo di Ricerca Dipartimentale 2024, Università degli Studi di Ferrara. “Significato biologico e clinico della eterogeneità istologica nel carcinoma del colon con deficit del mismatch repair”. Role in the project: Principal Investigator.

-2023: Fondo di Ricerca Dipartimentale 2023, Università degli Studi di Ferrara. “Identificazione di fattori prognostici nei carcinomi del colon con deficit del mismatch repair”. Role in the project: Principal Investigator.

-2023: Progetto PNRR-TR1-2023-12378111 “Longitudinal monitoring for the earliest and best management for pleural mesothelioma (LIFEBELT).” Role in the project: Collaborator.

-2022: Fondo di Ricerca Dipartimentale 2022, Università degli Studi di Ferrara. “Identificazione di parametri prognostici biomolecolari in tumori solidi”. Role in the project: Principal Investigator.

-2016: Fondo per l’Incentivazione alla Ricerca (FIR) - Anno 2016. Università degli Studi di Ferrara. “Analisi mutazionale del gene BRAF nella caratterizzazione clinico-patologica del carcinoma colorettale”. Role in the project: Principal Investigator.

-2007-2009: Programma di Ricerca Regione Università 2007-2009. Regione Emilia Romagna. “Identificazione di markers molecolari predittivi e prognostici per il trattamento dei pazienti con tumori solidi “. Role in the project: Collaborator.

-2005: AIRC Regional Grants AIRC 2005. “Early diagnosis and expression profiling classification of colorectal and liver metastasis”. Role in the project: Collaborator.

-2005: Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale. PRIN 2005.“Determinazione molecolare del rischio di metastasi epatiche nei pazienti con carcinoma colorettale”. Role in the project: Collaborator.

-2002: Progetto di Ricerca Lega Italiana per la Lotta contro i Tumori 2002. “Screening e sorveglianza di individui a rischio di tumore colorettale”. Role in the project: Collaborator.

-2002: Progetto strategico CNR-MIUR Oncologia 2002. “Identificazione di marcatori prognostici genetici e biomolecolari nel carcinoma del colon-retto stadio II e III”. Role in the project: Collaborator.

-2001: Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale. PRIN 2001. “Caratterizzazione morfofenotipica e biomolecolare del carcinoma colorettale”. Role in the project: Collaborator.

-2001: Progetto Giovani Ricercatori Anno 2001, Università degli Studi di Ferrara. “Polipi iperplastici ed adenomi serrati: ruolo nella istogenesi del carcinoma colorettale sporadico con instabilità dei microsatelliti”. Role in the project: Principal Investigator.

-2000: Progetto Giovani Ricercatori Anno 2000, Università degli Studi di Ferrara. “Micrometastasi linfonodali occulte nel carcinoma colorettale stadio B di Dukes: significato prognostico e relazione con le caratteristiche genetiche del tumore primitivo”. Role in the project: Principal Investigator.